FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119827939> ?p ?o ?g. }

• W3119827939 endingPage "116" @default.
• W3119827939 startingPage "108" @default.
• W3119827939 abstract "Objective We sought to compare the efficacy and safety of conjunctival autograft (CAG), amniotic membrane transplantation (AMT) with postoperative interferon alfa-2b (IFN alfa-2b), and modified conjunctival autograft plus amniotic membrane transplantation (mCAG plus AMT) with postoperative IFN alfa-2b for primary pterygium. Design Randomized controlled clinical trial. Methods Eyes with nasal and primary pterygia were randomized in a 1:1:1 ratio to receive CAG, AMT with IFN alfa-2b, or mCAG plus AMT with IFN alfa-2b. Subjects were followed up for 12 months. Primary outcomes included recurrence rate and complications. Secondary outcomes included corneal epithelium status, ocular surface symptom score, and visual acuity change. Results Eighty-five subjects (30 in the CAG group, 25 in the AMT group, and 30 in the CAG+AMT group) completed the 12-month follow-up. No complication or grade 4 recurrence was found. There was no significant difference among the 3 groups in recurrence grade, corneal epithelium status, and visual acuity change. Compared with mCAG+AMT, CAG has a negative effect (β = −0.62, P = .001), and AMT has a negative effect (β = −2.02, P < .001) on postoperative symptom scores. Compared with AMT, CAG has a positive effect (β = 1.28, P < .001) on postoperative symptom scores. Conclusions All 3 strategies had good safety and clinical efficacy in the study. Compared with conjunctival autograft, the 2 surgeries using no autograft or limited autograft was less traumatic and gave more flexibility for future ocular surface condition changes. We sought to compare the efficacy and safety of conjunctival autograft (CAG), amniotic membrane transplantation (AMT) with postoperative interferon alfa-2b (IFN alfa-2b), and modified conjunctival autograft plus amniotic membrane transplantation (mCAG plus AMT) with postoperative IFN alfa-2b for primary pterygium. Randomized controlled clinical trial. Eyes with nasal and primary pterygia were randomized in a 1:1:1 ratio to receive CAG, AMT with IFN alfa-2b, or mCAG plus AMT with IFN alfa-2b. Subjects were followed up for 12 months. Primary outcomes included recurrence rate and complications. Secondary outcomes included corneal epithelium status, ocular surface symptom score, and visual acuity change. Eighty-five subjects (30 in the CAG group, 25 in the AMT group, and 30 in the CAG+AMT group) completed the 12-month follow-up. No complication or grade 4 recurrence was found. There was no significant difference among the 3 groups in recurrence grade, corneal epithelium status, and visual acuity change. Compared with mCAG+AMT, CAG has a negative effect (β = −0.62, P = .001), and AMT has a negative effect (β = −2.02, P < .001) on postoperative symptom scores. Compared with AMT, CAG has a positive effect (β = 1.28, P < .001) on postoperative symptom scores. All 3 strategies had good safety and clinical efficacy in the study. Compared with conjunctival autograft, the 2 surgeries using no autograft or limited autograft was less traumatic and gave more flexibility for future ocular surface condition changes." @default.
• W3119827939 created "2021-01-18" @default.
• W3119827939 creator A5007661222 @default.
• W3119827939 creator A5023967052 @default.
• W3119827939 creator A5027418944 @default.
• W3119827939 creator A5030574650 @default.
• W3119827939 creator A5031307548 @default.
• W3119827939 creator A5055640195 @default.
• W3119827939 creator A5064030220 @default.
• W3119827939 creator A5087128953 @default.
• W3119827939 date "2021-05-01" @default.
• W3119827939 modified "2023-09-24" @default.
• W3119827939 title "The Effect of a Novel Strategy in Treating Primary Pterygium: A Prospective Randomized Clinical Study" @default.
• W3119827939 cites W1621542221 @default.
• W3119827939 cites W1967846957 @default.
• W3119827939 cites W1971613885 @default.
• W3119827939 cites W1984434168 @default.
• W3119827939 cites W1987759761 @default.
• W3119827939 cites W1997799788 @default.
• W3119827939 cites W2008178734 @default.
• W3119827939 cites W2015737367 @default.
• W3119827939 cites W2020929815 @default.
• W3119827939 cites W2021640684 @default.
• W3119827939 cites W2044109289 @default.
• W3119827939 cites W2062117542 @default.
• W3119827939 cites W2074929330 @default.
• W3119827939 cites W2101468606 @default.
• W3119827939 cites W2109358583 @default.
• W3119827939 cites W2111486118 @default.
• W3119827939 cites W2115076925 @default.
• W3119827939 cites W2147255310 @default.
• W3119827939 cites W2151017560 @default.
• W3119827939 cites W2328057926 @default.
• W3119827939 cites W2337258665 @default.
• W3119827939 cites W2469293680 @default.
• W3119827939 cites W2536886210 @default.
• W3119827939 cites W2578050687 @default.
• W3119827939 cites W2592412503 @default.
• W3119827939 cites W2736467056 @default.
• W3119827939 cites W2769445506 @default.
• W3119827939 cites W2769863126 @default.
• W3119827939 cites W2960511059 @default.
• W3119827939 doi "https://doi.org/10.1016/j.ajo.2021.01.001" @default.
• W3119827939 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33453159" @default.
• W3119827939 hasPublicationYear "2021" @default.
• W3119827939 type Work @default.
• W3119827939 sameAs 3119827939 @default.
• W3119827939 citedByCount "6" @default.
• W3119827939 countsByYear W31198279392021 @default.
• W3119827939 countsByYear W31198279392022 @default.
• W3119827939 countsByYear W31198279392023 @default.
• W3119827939 crossrefType "journal-article" @default.
• W3119827939 hasAuthorship W3119827939A5007661222 @default.
• W3119827939 hasAuthorship W3119827939A5023967052 @default.
• W3119827939 hasAuthorship W3119827939A5027418944 @default.
• W3119827939 hasAuthorship W3119827939A5030574650 @default.
• W3119827939 hasAuthorship W3119827939A5031307548 @default.
• W3119827939 hasAuthorship W3119827939A5055640195 @default.
• W3119827939 hasAuthorship W3119827939A5064030220 @default.
• W3119827939 hasAuthorship W3119827939A5087128953 @default.
• W3119827939 hasConcept C118487528 @default.
• W3119827939 hasConcept C126322002 @default.
• W3119827939 hasConcept C141071460 @default.
• W3119827939 hasConcept C159047783 @default.
• W3119827939 hasConcept C168563851 @default.
• W3119827939 hasConcept C188816634 @default.
• W3119827939 hasConcept C2776178377 @default.
• W3119827939 hasConcept C2776882836 @default.
• W3119827939 hasConcept C2778257484 @default.
• W3119827939 hasConcept C2778266423 @default.
• W3119827939 hasConcept C2779257441 @default.
• W3119827939 hasConcept C2781228144 @default.
• W3119827939 hasConcept C2909179924 @default.
• W3119827939 hasConcept C2911091166 @default.
• W3119827939 hasConcept C535046627 @default.
• W3119827939 hasConcept C71924100 @default.
• W3119827939 hasConcept C81182388 @default.
• W3119827939 hasConceptScore W3119827939C118487528 @default.
• W3119827939 hasConceptScore W3119827939C126322002 @default.
• W3119827939 hasConceptScore W3119827939C141071460 @default.
• W3119827939 hasConceptScore W3119827939C159047783 @default.
• W3119827939 hasConceptScore W3119827939C168563851 @default.
• W3119827939 hasConceptScore W3119827939C188816634 @default.
• W3119827939 hasConceptScore W3119827939C2776178377 @default.
• W3119827939 hasConceptScore W3119827939C2776882836 @default.
• W3119827939 hasConceptScore W3119827939C2778257484 @default.
• W3119827939 hasConceptScore W3119827939C2778266423 @default.
• W3119827939 hasConceptScore W3119827939C2779257441 @default.
• W3119827939 hasConceptScore W3119827939C2781228144 @default.
• W3119827939 hasConceptScore W3119827939C2909179924 @default.
• W3119827939 hasConceptScore W3119827939C2911091166 @default.
• W3119827939 hasConceptScore W3119827939C535046627 @default.
• W3119827939 hasConceptScore W3119827939C71924100 @default.
• W3119827939 hasConceptScore W3119827939C81182388 @default.
• W3119827939 hasLocation W31198279391 @default.
• W3119827939 hasOpenAccess W3119827939 @default.
• W3119827939 hasPrimaryLocation W31198279391 @default.
• W3119827939 hasRelatedWork W1484554393 @default.

• next